Dashboard
Manage Tickers

QUREuniQure N.V.

Nasdaq uniqure.com


$ 4.55 $ 0.16 (3.63 %)    

Wednesday, 01-May-2024 15:59:57 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 422.58 $ -3.07 (-0.72 %)
DIA $ 378.81 $ 0.76 (0.2 %)
SPY $ 500.35 $ -1.63 (-0.32 %)
TLT $ 88.50 $ 0.65 (0.74 %)
GLD $ 213.80 $ 1.92 (0.91 %)
$ 4.57
$ 4.51
$ 0.00 x 0
$ 0.00 x 0
$ 4.37 - $ 4.63
$ 4.25 - $ 22.48
696,978
na
218.5M
$ 1.15
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 02-28-2024 12-31-2023 10-K
2 11-07-2023 09-30-2023 10-Q
3 08-01-2023 06-30-2023 10-Q
4 05-09-2023 03-31-2023 10-Q
5 02-27-2023 12-31-2022 10-K
6 11-02-2022 09-30-2022 10-Q
7 08-08-2022 06-30-2022 10-Q
8 05-02-2022 03-31-2022 10-Q
9 02-25-2022 12-31-2021 10-K
10 10-25-2021 09-30-2021 10-Q
11 07-26-2021 06-30-2021 10-Q
12 05-10-2021 03-31-2021 10-Q
13 03-01-2021 12-31-2020 10-K
14 10-27-2020 09-30-2020 10-Q
15 07-30-2020 06-30-2020 10-Q
16 04-29-2020 03-31-2020 10-Q
17 03-02-2020 12-31-2019 10-K
18 10-28-2019 09-30-2019 10-Q
19 07-29-2019 06-30-2019 10-Q
20 04-29-2019 03-31-2019 10-Q
21 02-28-2019 12-31-2018 10-K
22 11-06-2018 09-30-2018 10-Q
23 08-08-2018 06-30-2018 10-Q
24 04-30-2018 03-31-2018 10-Q
25 03-14-2018 12-31-2017 10-K
26 11-01-2017 09-30-2017 10-Q
27 08-08-2017 06-30-2017 10-Q
28 05-09-2017 03-31-2017 10-Q
29 03-15-2017 12-31-2016 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

amd-to-rally-around-16-here-are-10-top-analyst-forecasts-for-monday
AMD To Rally Around 16%? Here Are 10 Top A...
03/04/2024 12:56:22

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...

mizuho-maintains-neutral-on-uniqure-lowers-price-target-to-7
Mizuho Maintains Neutral on uniQure, Lower...
03/04/2024 12:12:20

Mizuho analyst Uy Ear maintains uniQure (NASDAQ:QURE) with a Neutral and lowers the price target from $10 to $7.

hc-wainwright--co-maintains-buy-on-uniqure-lowers-price-target-to-25
HC Wainwright & Co. Maintains Buy on uniQu...
03/01/2024 19:12:12

HC Wainwright & Co. analyst Patrick Trucchio maintains uniQure (NASDAQ:QURE) with a Buy and lowers the price target from...

why-butterfly-network-shares-are-trading-lower-by-22-here-are-other-stocks-moving-in-thursdays-mid-day-session
Why Butterfly Network Shares Are Trading L...
02/29/2024 19:00:01

Shares of Butterfly Network, Inc. (NASDAQ: BFLY) fell sharply during Thursday’s session after the company reported mixed four...

goldman-sachs-downgrades-uniqure-to-neutral-lowers-price-target-to-8
Goldman Sachs Downgrades uniQure to Neutra...
02/29/2024 16:09:51

Goldman Sachs analyst Salveen Richter downgrades uniQure (NASDAQ:QURE) from Buy to Neutral and lowers the price target from ...

recap-uniqure-q4-earnings
Recap: uniQure Q4 Earnings
02/28/2024 14:50:13

rbc-capital-reiterates-outperform-on-uniqure-maintains-28-price-target
RBC Capital Reiterates Outperform on uniQu...
01/16/2024 14:12:01

RBC Capital analyst Luca Issi reiterates uniQure (NASDAQ:QURE) with a Outperform and maintains $28 price target.

cantor-fitzgerald-reiterates-overweight-on-uniqure-maintains-21-price-target
Cantor Fitzgerald Reiterates Overweight on...
12/20/2023 15:19:06

Cantor Fitzgerald analyst Kristen Kluska reiterates uniQure (NASDAQ:QURE) with a Overweight and maintains $21 price target.

why-compugen-shares-are-trading-higher-by-over-200-here-are-other-stocks-moving-in-tuesdays-mid-day-session
Why Compugen Shares Are Trading Higher By ...
12/19/2023 18:34:55

Shares of Compugen Ltd. (NASDAQ: CGEN) shares rose sharply during Tuesday’s session after Gilead announced an agreement with t...

bluebird-bio-vertex-energy-and-other-big-stocks-moving-lower-on-tuesday
Bluebird Bio, Vertex Energy And Other Big ...
12/19/2023 15:19:40

U.S. stocks traded higher, with the Dow Jones index gaining around 150 points on Tuesday. Shares of bluebird bio, Inc. (NASDA...

uniqure-announces-updated-interim-data-on-phase-iii-clinical-trials-of-amt-130-gene-therapy-for-the-treatment-of-huntingtons-disease
uniQure Announces Updated Interim Data On ...
12/19/2023 12:13:09

~ Patients treated with AMT-130 continue to show evidence of preserved neurological function with potential dose-dependent clin...

mizuho-downgrades-uniqure-to-neutral-announces-10-price-target
Mizuho Downgrades uniQure to Neutral, Anno...
12/19/2023 09:16:14

Mizuho analyst Uy Ear downgrades uniQure (NASDAQ:QURE) from Buy to Neutral and announces $10 price target.

uniqure-option-alert-jan-19-9-calls-sweep-10-near-the-ask-875--0698-vs-388-oi-ref783
uniQure Option Alert: Jan 19 $9 Calls Swee...
12/14/2023 15:45:57

csl-behrings-three-year-results-from-the-pivotal-hope-b-study-confirms-continued-long-term-durability-and-safety-of-hemgenix
CSL Behring's Three-Year Results From The ...
12/12/2023 07:26:58

HEMGENIX® is the first and only gene therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of hem...

the-fda-has-cleared-the-investigational-new-drug-application-for-uniqures-amt-191-gene-therapy-for-fabry-disease
The FDA Has Cleared The Investigational Ne...
11/29/2023 12:13:33

goldman-sachs-maintains-buy-on-uniqure-raises-price-target-to-63
Goldman Sachs Maintains Buy on uniQure, Ra...
11/08/2023 13:41:16

Goldman Sachs analyst Salveen Richter maintains uniQure (NASDAQ:QURE) with a Buy and raises the price target from $56 to $63.

gene-therapy-player-uniqure-to-lay-off-20-of-workforce-stop-parkinsons-study
Gene Therapy Player UniQure To Lay Off 20%...
10/05/2023 14:23:34

uniQure N.V. (NASDAQ: QURE) announced to cut about 20% of its total workforce, or about 114 jobs, and end investments in more t...

uniqure-shares-resumed-trading-higher-after-co-announced-strategic-reorganization
Uniqure Shares Resumed Trading Higher Afte...
10/05/2023 11:42:21

uniqure-plans-discontinuing-investments-in-more-than-half-of-research-and-technology-projects-chief-scientific-officer-ricardo-dolmetsch-to-depart-company
uniQure Plans Discontinuing Investments In...
10/05/2023 11:12:57

uniqure-nv-shares-to-resume-trade-at-735-am-et
uniQure NV Shares To Resume Trade At 7:35 ...
10/05/2023 11:12:06

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION